AstraZeneca is actively involved in sponsoring and/or attending many international partnering and business development conferences as an integral component of our Externalisation strategy. Senior decision makers from Strategic Planning and Business Development welcome the opportunity to meet you at conferences arranged by various organisations within the life science industry throughout the year at international venues.
| 2009 | |
|---|---|
| 11-15 January | JP Morgan Healthcare Conference, San Fransisco, US |
| 19-20 January | BIO Asia, Tokyo, Japan |
| 8-10 February | BioPartnering North America, Vancouver, Canada |
| 12-14 February | AUTM, Orlando, Florida |
| 16-18 March | BIO-Europe Spring, Milan Italy |
| 13-15 April | BioWindhover/Pharmaceutical Strategic Outlook, NYC, US |
| 18-21 May | BIO International Convention, Atlanta, Georgia |
| 25-28 June | |
| 23-25 September | Pharmaceutical Strategic Alliances, Windhover, NYC, US |
| 12-13 October | BioPartnering Europe, London, UK |
| 2-4 November | BIO-Europe, Vienna, Austria |
AstraZeneca contact: Chris Yochim
E-mail: firstname.lastname@astrazeneca.com (replace with authentic names)
Conferences are added as they are scheduled.
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 03:08 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
